JNJ Holds Strong Near 52-Week High Amid Mixed Market Signals and Geopolitical Tensions

# Johnson & Johnson Stock Analysis: JNJ Trading at $240.40 with Analyst Upgrades | March 2026 Market Update Discover the latest **Johnson & Johnson (JNJ) stock analysis** as shares trade at $240.40 on March 10, 2026. This comprehensive podcast episode breaks down JNJ's current market position, featuring recent analyst upgrades from Wolfe Research and Daiwa Capital Markets. In this episode, we examine: - **JNJ stock price movement**: Up 0.32% with trading volume exceeding 7.1 million shares - **Analyst consensus and price targets**: 26 analysts project targets averaging $199-$237, with recent upgrades to "outperform" and "strong buy" ratings - **Dividend information**: $1.30 quarterly dividend with 0.636% yield - **Market context**: How rising oil prices ($119/barrel) amid Iran tensions may impact healthcare sector margins - **52-week performance**: Stock trading near its high of $248.56 Whether you're a Johnson & Johnson shareholder, healthcare sector investor, or market analyst, this episode provides essential insights into JNJ's fundamentals and technical position. Data sourced from Tickeron, MarketBeat, StockAnalysis, and Johnson & Johnson investor relations. **Subscribe for daily stock market analysis and investment insights.** *A Quiet Please Studios production | Visit quietplease.ai for more financial podcasts* **Keywords**: Johnson & Johnson stock, JNJ stock analysis, healthcare stocks, dividend stocks, pharmaceutical stocks, stock market analysis 2026 For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.